Drug Repurposing for AML: Structure-Based Virtual Screening and Molecular Simulations of FDA-Approved Compounds with Polypharmacological Potential. [PDF]
Abdelsayed M, Boulaamane Y.
europepmc +1 more source
Olutasidenib: an Achilles' heel for IDH1-mutated MDS? [PDF]
Wiser L, Lachowiez C.
europepmc +1 more source
Molecular abnormalities and clinical features in adult patients with acute myeloid leukemia in Thailand. [PDF]
Chantrathammachart P +11 more
europepmc +1 more source
IDH mutations are rare events in SHH medulloblastoma. [PDF]
Fürst A +9 more
europepmc +1 more source
Utility of IDH1/2 mutations as biomarkers for detection of measurable residual disease in acute myeloid leukemia. [PDF]
Boertjes EL +10 more
europepmc +1 more source
Molecular Characterization of Adult-Type Lower-Grade Glioma (WHO Grade 1-3) with Targeted Next-Generation Sequencing: A Retrospective, Single-Institution Experience. [PDF]
Pinamonti M +9 more
europepmc +1 more source
Single-cell proteogenomic analysis of clonal evolution in PDX models of AML treated with IDH inhibitors. [PDF]
Liu ACH +19 more
europepmc +1 more source
Ultra-Fast Intraoperative <i>IDH</i>-Mutation Analysis Enables Rapid Stratification and Therapy Planning in Diffuse Gliomas. [PDF]
Kraus TFJ +11 more
europepmc +1 more source
Supplementary Figure S4 from UBE2T-Mediated HP1α Ubiquitination Enhances Nucleolar Function and Promotes the Progression of IDH1/TP53-Mutant Glioma [PDF]
Fengqi Zhou +8 more
openalex +1 more source

